You are here: Industry Insights > Strides Shasun

News List

Strides Shasun gets WHO pre-qualification for rectal artesunate product financialexpress
June 29, 2018
Strides Shasun has received pre-qualification from the World Health Organization (WHO) for its rectal artesunate product for the pre-referral management of severe malaria. The pre-qualification from the WHO
Strides Shasun receives USFDA approval for Cinacalcet Hydrochloride tablets biospectrumasia
May 03, 2018
Cinacalcet Hydrochloride tablets is a generic version of Sensipar tablets of Amgen Inc
Strides Shasun’s generic Ibuprofen receives USFDA approval biospectrumasia
April 03, 2018
The company's product is a generic version of Pfizer Inc's Advil Liqui-Gels 200 mg
Strides Shasun receives US FDA approval expressbpd
January 30, 2018
The company received the approval for Tenofovir Disoproxil Fumarate Tablets, 300 mg from the United States Food & Drug Administration
Strides Shasun divests India brand business to Eris Lifesciences for Rs 500 cr expressbpd
November 20, 2017
Strides Shasun and Eris Lifesciences have entered into definitive agreements for sale of Strides’ India branded generics business to Eris for an aggregate cash consideration of Rs 500 crores.
Strides Shasun receives USFDA approval for Potassium Citrate Extended-Release Tablets expressbpd
September 13, 2017
Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq
Strides Shasun receives US FDA Approval for Cetirizine Softgel Capsules expressbpd
July 25, 2017
First Indian generic company to receive approval for Cetirizine (Softgel)